Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts

Coverage, in order

1. 7d ago
   
   first Guardian Australia Health Australia mainstream study

   Australia’s first GLP-1 weight-loss pill has been approved. How does it differ to injections and who will be eligible?

   Wegovy tablets will be going on sale soon as a daily dose after TGA approval, but with restrictions and still plenty of unknowns Get our breaking news email , free app or daily news podcast Australia’s first GLP-1 pill for weight loss has been approved for sale, meaning patients will be able to…

2. 7d ago
   
   The Conversation Australia Health Australia indie

   Australia is set to get a Wegovy pill. How does it compare with weight-loss injections?

   UCG/Contributor/Getty A new tablet version of Wegovy , a peptide used to help people lose weight, has been approved for the first time in Australia. Until now, the best-known medicines in this group ( semaglutide , sold as Wegovy or Ozempic, and tirzepatide, sold as Mounjaro), have generally…

3. 7d ago
   
   WSJ Health mainstream

   Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues

   The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.

4. 7d ago
   
   Medical Xpress indie

   Australia is set to get a Wegovy pill. How does it compare with weight‑loss injections?

   A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.

5. 7d ago
   
   BioPharma Dive indie

   Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts

   The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.